140 likes | 241 Vues
Chronic Myelogenous Leukemia (CML) is a type of cancer that affects the blood and bone marrow. It is characterized by the overproduction of myeloid cells. This disease typically develops slowly and may not show symptoms in its early stages. Common symptoms include fatigue, night sweats, and an enlarged spleen. Treatment options include targeted therapies like imatinib, which inhibit cancer cell growth. Regular monitoring and medical guidance are essential for managing this condition and improving patient outcomes.
E N D
vti_cachedlinkinfo:VX|H|http://www.emedicine.com/cgi-bin/foxweb.exe/makezoom@/em/makezoom H|http://www.emedicine.com/cgi-bin/foxweb.exe/makezoom@/em/makezoom H|http://www.emedicine.com/cgi-bin/foxweb.exe/makezoom@/em/makezoom
vti_cachedsvcrellinks:VX|NHHS|http://www.emedicine.com/cgi-bin/foxweb.exe/makezoom@/em/makezoom NHHS|http://www.emedicine.com/cgi-bin/foxweb.exe/makezoom@/em/makezoom NHHS|http://www.emedicine.com/cgi-bin/foxweb.exe/makezoom@/em/makezoom